71
TITLE: Antiretroviral resistance in different HIV-1 subtypes: impact on therapy outcomes and resistance testing interpretation
AUTHORS: Ricardo Jorge Camacho; Anne Mieke Vandamme ;
PUBLISHED: 2007, SOURCE: CURRENT OPINION IN HIV AND AIDS, VOLUME: 2, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
72
TITLE: Proof-of-principle evaluation of predictive performance for therapy outcome of baseline estimated fitness and genetic barrier towards resistance in a clinical cohort of HIV-1-treated patients
AUTHORS: Deforche, K; Cozzi Lepri, A; Theys, K; Clotet, B; Camacho, R; Kjaer, J; Van Laethem, K; Phillips, AN; Moreau, Y; Lundgren, JD; Vandamme, AM;
PUBLISHED: 2007, SOURCE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12
INDEXED IN: WOS
73
TITLE: Proof-of-principle evaluation of predictive performance for therapy outcome of baseline estimated fitness and genetic barrier towards resistance in a clinical cohort of HIV-1-treated patients
AUTHORS: Deforche, K; Cozzi Lepri, A; Theys, K; Clotet, B; Camacho, R; Kjaer, J; Van Laethem, K; Phillips, AN; Moreau, Y; Lundgren, JD; Vandamme, AM;
PUBLISHED: 2007, SOURCE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12, ISSUE: 5
INDEXED IN: WOS
74
TITLE: Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance  Full Text
AUTHORS: Deforche, K; Silander, T; Camacho, R; . Grossman; Soares, MA; Van Laethem, K; Kantor, R; Moreau, Y; M Vandamme ;
PUBLISHED: 2006, SOURCE: BIOINFORMATICS, VOLUME: 22, ISSUE: 24
INDEXED IN: Scopus WOS CrossRef
75
TITLE: Comparison of the COBAS TAQMAN (TM) HIV-1HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation indifferent HIV-1 subtypes  Full Text
AUTHORS: Perpetua Gomes ; Ana Carolina Palma; Joaquim Cabanas; Ana Abecasis ; Ana Patricia Carvalho; Rainer Ziermann; Isabel Diogo; Fatima Gonccalves; Ceu Sousa Lobo; Ricardo Camacho;
PUBLISHED: 2006, SOURCE: JOURNAL OF VIROLOGICAL METHODS, VOLUME: 135, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 11
76
TITLE: What have we learned from recent CD4-guided treatment interruption studies?
AUTHORS: Ricardo Camacho;
PUBLISHED: 2006, SOURCE: AIDS REVIEWS, VOLUME: 8, ISSUE: 3
INDEXED IN: WOS
77
TITLE: HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes
AUTHORS: Rhee, SY; Kantor, R; Katzenstein, DA; Camacho, R; Morris, L; Sirivichayakul, S; Jorgensen, L; Brigido, LF; Schapiro, JM; Shafer, RW;
PUBLISHED: 2006, SOURCE: AIDS, VOLUME: 20, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef
78
TITLE: The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
AUTHORS: van de Vijver, DA; Wensing, AMJ; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, ML; Costagliola, D; De Luca, A; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hemmer, R; Hoepelman, A; Horban, A; Korn, K; Kucherer, C; Leitner, T; Loveday, C; MacRae, E; Maljkovic, I; de Mendoza, C; Meyer, L; Nielsen, C; de Coul, ELMO; Ormaasen, V; Paraskevis, D; Perrin, L; Puchhammer Stockl, E; Ruiz, L; Salminen, M; Schmit, JC; Schneider, F; Schuurman, R; Soriano, V; Stanczak, G; Stanojevic, M; Vandamme, AM ; Van Laethem, K; Violin, M; Wilbe, K; Yerly, S; Zazzi, M; Boucher, CAB; ...More
PUBLISHED: 2006, SOURCE: 13th International HIV Drug Resistance Workshop in JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 41, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
80
TITLE: Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG
AUTHORS: Ana B Abecasis ; Koen Deforche; Lee T Bacheler; Paula McKenna; Ana Patricia Carvalho; Perpetua Gomes ; Anne Mieke Vandamme ; Ricardo Jorge Camacho;
PUBLISHED: 2006, SOURCE: ANTIVIRAL THERAPY, VOLUME: 11, ISSUE: 5
INDEXED IN: Scopus WOS
Página 8 de 10. Total de resultados: 92.